The value of testing for ATXN2 intermediate repeat expansions in routine clinical practice for amyotrophic lateral sclerosis

Eur J Hum Genet. 2022 Nov;30(11):1205-1207. doi: 10.1038/s41431-022-01146-2. Epub 2022 Jul 21.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyotrophic Lateral Sclerosis* / genetics
  • Ataxin-2 / genetics
  • C9orf72 Protein / genetics
  • DNA Repeat Expansion
  • Genetic Association Studies
  • Humans
  • Trinucleotide Repeat Expansion

Substances

  • C9orf72 Protein
  • ATXN2 protein, human
  • Ataxin-2

Grants and funding